RVMD insider trading
Revolution Medicines, Inc.
In the past 36 days, 8 insiders sold $33.1M.
Insider purchases
No open-market purchases by insiders in this period.
Insider sales
| Insider | Value | Holdings | Plan | Traded / filed |
|---|---|---|---|---|
Alan B. Sandler Chief Development Officer |
$1.3M 6,309 sh @ $202.14 |
−10.7% | Pre-scheduled | Sep 29, 2026 Filed Oct 1, 2026 |
Jeff Cislini SVP & General Counsel |
$159K 765 sh @ $207.32 |
−1.5% | Pre-scheduled | Sep 25, 2026 Filed Sep 29, 2026 |
Anthony Mancini See Remarks |
$743K 3,708 sh @ $200.45 |
−8.5% | Pre-scheduled | Sep 24, 2026 Filed Sep 28, 2026 |
Elizabeth M Anderson Director |
$2.0M 10,143 sh @ $193.04 |
−70.1% | Pre-scheduled | Sep 22, 2026 Filed Sep 24, 2026 |
Anthony Mancini See Remarks |
$347K 1,764 sh @ $196.94 |
−4.2% | Pre-scheduled | Sep 18, 2026 Filed Sep 22, 2026 |
Mark A Goldsmith See Remarks |
$2.8M 13,988 sh @ $199.24 |
−5.2% | Pre-scheduled | Sep 16, 2026 Filed Sep 18, 2026 |
Stephen Michael Kelsey See Remarks |
$1.1M 5,569 sh @ $199.24 |
−1.9% | Pre-scheduled | Sep 16, 2026 Filed Sep 18, 2026 |
Margaret A Horn Chief Operating Officer |
$990K 4,967 sh @ $199.24 |
−3.2% | Pre-scheduled | Sep 16, 2026 Filed Sep 18, 2026 |
Jack Anders Chief Financial Officer |
$808K 4,053 sh @ $199.24 |
−3.3% | Pre-scheduled | Sep 16, 2026 Filed Sep 18, 2026 |
Jeff Cislini SVP & General Counsel |
$671K 3,366 sh @ $199.24 |
−6.0% | Pre-scheduled | Sep 16, 2026 Filed Sep 18, 2026 |
Anthony Mancini See Remarks |
$353K 1,774 sh @ $199.24 |
−4.0% | Pre-scheduled | Sep 16, 2026 Filed Sep 18, 2026 |
Alan B. Sandler Chief Development Officer |
$68K 341 sh @ $199.24 |
−0.6% | Pre-scheduled | Sep 16, 2026 Filed Sep 18, 2026 |
Stephen Michael Kelsey See Remarks |
$18.7M 92,531 sh @ $202.36 |
−24.1% | Pre-scheduled | Sep 11, 2026 Filed Sep 15, 2026 |
Anthony Mancini See Remarks |
$3.2M 15,448 sh @ $204.16 |
−26.0% | Pre-scheduled | Sep 10, 2026 Filed Sep 14, 2026 |